Organization and characterization of a biosynthetic gene cluster for bafilomycin from Streptomyces griseus DSM 2608
© Hwang et al.; licensee Springer. 2013
Received: 24 April 2013
Accepted: 2 May 2013
Published: 10 May 2013
Streptomyces griseus DSM 2608 produces bafilomycin, an antifungal plecomacrolide antibiotic. We cloned and sequenced an 87.4-kb region, including a polyketide synthase (PKS) region, methoxymalonate genes, flavensomycinate genes, and other putative regulatory genes. The 58.5kb of PKS region consisting 12 PKS modules arranged in five different PKS genes, was assumed to be responsible for the biosynthesis of plecomacrolide backbone including 16-membered macrocyclic lactone. All the modules showed high similarities with typical type I PKS genes. However, the starting module of PKS gene was confirmed to be specific for isobutyrate by sequence comparison of an acyltransferase domain. In downstream of PKS region, the genes for methoxymalonate biosynthesis were located, among which a gene for FkbH-like protein was assumed to play an important role in the production of methoxymalonyl-CoA from glyceryl-CoA. Further the genes encoding flavensomycinyl-ACP biosynthesis for the post-PKS tailoring were also found in the upstream of PKS region. By gene disruption experiments of a dehydratase domain of module 12 and an FkbH-like protein, this gene cluster was confirmed to be involved in the biosynthesis of bafilomycin.
KeywordsStreptomyces griseus Bafilomycin Plecomacrolide antibiotic Polyketide synthase
Plecomacrolide antibiotic is an unusual class of macrolide antibiotic which has a structural element of 6-membered hemiacetal ring connected to the macrolactone ring by C3-spacer (Dröse and Altendorf 1997). In early 1980s, two macrolides were discovered: one was bafilomycin showing antifungal activity (Werner et al. 1984) and the other concanamycin screened as an immunosuppressive compound (Kinashi et al. 1984). Later some other compounds in this category were further found from nature, including hygrolidin (Seto et al. 1984), setamycin (Otoguro et al. 1988), leucancidin (O’Shea et al. 1997), micromonospolide (Ohta et al. 2001), and so on.
In early days, plecomacrolide antibiotics were found to have a wide spectrum of activities including antifungal, antimalarial and antiparasitic activity as well as antibacterial activity against Gram-positive bacteria. Since Bowman et al. (1988) reported that bafilomycin shows a high-affinity inhibitory function on vacuolar-type ATPase (V-ATPase), this compound became a widely-used biochemical research tool to study the function of this type of ATPases. Interestingly, this class of antibiotics makes a clear distinctive inhibition of V-ATPase activity from other type of ATPases (P-ATPase and F-ATPase), which can promote the accumulation of autophagic vacuoles and trigger Bax-dependent autophagy (Shacka et al. 2006). This specific inhibitory function suggests the possibility of clinical application in the treatment of osteoporosis associated with excessive bone resorption (Farina and Gagliardi 2002;Xu et al. 2007).
The unusual structure of plecomacrolide antibiotics evokes researcher’s interests about their biosynthetic pathway. Schumann and his collegues (2004; 2007) reported the biosynthetic origin of bafilomycin and concanamycin by feeding experiments with 13C-labelled precursors. They assumed that the main backbone of plecomacrolide including macrolactone and hemiacetal ring is assembled from an isobutyrate starter unit, 7 propionate extender units, 2 acetate extender units, and 2 methoxyl C2 extender units, on the modular type I polyketide synthases (PKSs). They proposed that the methoxymalonyl CoA for methoxyl C2 extender units could be derived from glycerol through D-1,3-bisphosphoglycerate.
The first plecomacrolide antibiotic of which the biosynthetic gene cluster was reported is concanamycin A of Streptomyces neyagawaensis (Haydock et al. 2005). In this cluster, genes for a set of polyketide synthases encoding 14 modules and for deoxysugar biosynthesis were found. Recently, the genome sequence of Kitasatospora setae producing bafilomycin has been revealed (Ichikawa et al. 2010). Among 24 gene clusters for secondary metabolite biosynthesis, the predictive gene cluster for bafilomycin biosynthesis was located in the left subtelomeric region. However, the authors did not further characterize this gene cluster beyond indentifying its putative gene sequences.
Here we report the full gene cluster for bafilomycin biosynthesis from Streptomyces griseus DSM 2608, which was formerly reported as Tü 1922 (Werner et al. 1984;Hagenmaier et al. 1985). The involvement of this gene cluster in bafilomycin biosynthesis was also confirmed by gene disruption experiments.
Materials and methods
Strains, vectors, culture media and reagents
Escherichia coli XL1-blue, E. coli XL1-blue MRF’ and E. coli JM109 grown on Luria-Bertani (LB) medium at 37°C were used routinely for gene manipulation in this study. The cloning vectors pGEM-T-easy, pUC18 or pUC19 plasmid were generally employed for subcloning. For blue/white selection, 0.1 mM of isopropyl-D-thiogalactopyranoside (IPTG), and 80 μg ml-1 of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal) were added on the medium, and for positive selection, appropriated antibiotic solutions were also supplemented. In gene disruption experiment, E. coli BW25113/pIJ790 cultured on SOC medium (2% trypton, 0.5% yeast extract, 0.05% NaCl, 2.5 mM KCl, 10 mM MgCl2, 20 mM glucose, pH 7.0) was used for homologous double-crossover recombination (Datsenko and Wanner 2000) and E. coli ET12567/pUZ8002 grown on LB medium for conjugation (Biermann et al. 1992). The induction of an ara promoter in pIJ790 plasmid was achieved by the addition of 10 mM arabinose to LB agar medium, and pIJ773 plasmid was used as a template for the construction of disruption cassette. The bafilomycin-producer S. griseus DSM 2608 was cultivated on tryptic soy broth (TSB) at 28°C for 3 days for simple culture, or mannitol soy flour (MS) agar (2% mannitol, 2% soy flour, 2% agar) for the selection of gene disruptants. The fermentation of this strain was carried out on the production agar medium (2% glucose, 1% soluble starch, 0.1% meat extract, 0.4% yeast extract, 2.5% soybean meal, 0.2% NaCl, 0.005% K2HPO4, pH 7.3) (Moon et al. 2003). The antifungal activity was measured using Rhizoctonia solani AG-1 (KACC 40401) grown on potato dextrose agar medium. The authentic bafilomycin A1 was purchased from Fermentek (Israel) and bafilomymycin B1 from Santa Cruz Biotech (USA).
Preparation of probes for gene screening
For screening the bafilomycin biosynthetic gene cluster, three different gene fragments of ketosynthase (KS), aminolevulinate synthase (ALS) and FkbH-like protein were amplified from S. griseus chromosomal DNA based on their conserved domains. The chromosomal DNA of S. griseus DSM 2608 was isolated from mycelia following the procedure using 10% cetyltrimethylammonium bromide (CTAB) (Kieser et al. 2000). The primers used for gene amplification by polymerase chain reaction (PCR) were as follows : KS-F (5′-SBVBTTCGACGCSBSSTTCTTCG-3′), KS-R (5′-RCSAGSGASGASGAGCASGCSGTGTC-3′), ALS-F (5′-AGGAACTAGCGGATCTGCAC-3′), ALS-R1 (5′-ACGAAGATCGA GACGATGTG-3′), FkbH-F (5′-AARTGYCTSGTCTGGGACCTSGACRACACMCTSTGGC-3′), and FkbH-R (5′-GCGTTCATCTGGCTGGTGCGCAGGGTSAGTTCCTCGACCC-3′). The extension of the biosynthetic gene cluster, a new primer set was also designed as follows: ACL-F (5′-GAGGGGGAAGGCGTCCACGAACTCCACCCGGCGCGGGTACTTGTA-3′) and ALS-R2 (5′-AATTTTCCGGCGAGCCGGCCCAGTTCGAGGAACTCCCGTTTCGCAT-3′). A typical amplification conditions were as follows: an initial hot start at 94°C for 5 min; 35 cycles of amplification with each repeat of denaturation at 30 sec at 94°C, annealing at 52.5°C for 30 sec, and elongation at 72°C for 30 sec; and final completion at 72°C for 5 min. The amplified probes were radiolabeled with α-[32P]-dCTP (10 mCi ml-1; Perkin Elmer, USA) by DecaLabel™ DNA labeling kit (Thermo Scientific, UK), and purified by passing through a Elutip-D column (Schleicher & Shuell, Germany).
Construction and screening of cosmid library of genomic DNA
The obtained chromosomal DNA was partially digested with Mbo I, and the DNA fragments larger than 23 kb were excised from agarose gel and then ligated with Bam HI-digested and dephosphorylated SuperCos1 cosmid vector. The ligated DNA products were then in vitro packaged using Gigapack III packaging extract (Stratagene, USA). After adding SM buffer (phage dilution buffer), the ligated cosmid DNAs (ca 5 μg) were then transfected into E. coli XL1-blue MRF’ grown overnight on LB broth supplemented with 10 mM MgSO4. The host cells were then incubated on LB liquid media containing ampicillin. The appeared colonies were transferred to Nylon membrane by placing it on the agar plate, and subjected to in situ hybridization with 32P-labeled probes (Sambrook et al. 1989).
DNA sequencing and analysis
The selected recombinant cosmids were sent to Genotech Co., Inc. (Daejeon, Korea) for sequencing. The location of the open reading frames (ORFs) in the sequences was determined using FramePlot version 2.3.2 (http://www0.nih.go.jp/~jun/cgi-bin/frameplot.pl) (Ishikawa and Hotta 1999). The homology search with the obtained DNA or protein sequences was performed with BLAST program (http://blast.ncbi.nlm.nih.gov). The multiple alignments of DNA or protein sequences were performed with EBI–ClustalW2 program (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
The gene disruption was performed following the protocol of John Innes Centre (Gust et al. 2003). Employing pIJ773 plasmid as a template, the disruption cassette for a dehydratase domain of module 12 was amplified using forward primer (5′-GCCTGCGGGTCGACTGGGAGCGGCTGTTCGCGGGGACCATTCCGGGGATCCGTCGACC-3′) and reverse primer (5′-GGTGTTCGAGCTGGGCCGCGGCGAGCATGCCCCGAACGGTGTAGGCTGGAGCTGCTTC-3′), and that for a FkbH-like protein was also amplified using forward primer (5′-AGCGGGCCCGCGTCCGACGAGACGAGGAAGGACGACATGATTCCGGGGATCCGTCGACC-3′) and reverse primer (5′-CGGGCCGGAGCCCGGGAGCACCGGCCGCCGCGGCGGTCATGTAGGCTGGAGCTGCTTC-3′). These extended apramycin disruption cassettes were introduced by electroporation into cell suspension of E. coli BW25113/pIJ790 harboring pSGB20 cosmid, which were grown in the presence of arabinose. After incubation overnight at 37°C, a single clone was selected in which the target gene was replaced by the disruption cassette. For conjugal transfer to bafilomycin-producing S. griseus, the PCR-targeted disruption cosmid was purified and transformed in E. coli ET12567/pUZ8002 by electroporation, and then transferred by intergeneric conjugation to wild strain. The conjugation was tried using Streptomyces spores obtained from MS agar plate and then heated at 50°C for 10 min to induce germination. The mixture of E. coli ET12567/pUZ8002 cells and heated spores were spread on MS agar plate supplemented with 10 mM MgCl2 and apramycin at 30°C overnight. One day after, the plates were overlaid with 300 μL of apramycin and nalidixic acid and incubated for 5 days more. For selection of the disrupted colonies, replica-plates with single colonies were made onto a nutrient agar containing nalidixic acid and apramycin for positive selection, and the other onto a nutrient agar containing nalidixic acid, apramycin and kanamycin for negative selection.
The wild strain and the gene disuptants were cultured on the production agar plates (pH 7.3) at 28°C for 7 days. The plates were minced and directly extracted twice with ethyl acetate. After drying on anhydrous sodium sulfate and concentration in vacuo, the extracts dissolved in chloroform-methanol (9:1) were chromatographed on Kieselgel 60 (0.063~0.200 mm, Merck, Germany) with the same solvent. The fractions of wild-type showing the antimicrobial activity against R. solani were collected. Once more purification was performed by chromatography on Lichroprep Si 60 (40–63 μm; Merck, Germany) with the solvent system of chloroform-methanol (95:5), and the antimicrobial fractions were also collected. In case of disruptants, the fractions corresponding to the same elution number were collected. The fractions were dried and applied on high-performance liquid chromatography (SCL-10AVP system, Shimadzu Co., Japan) using YMC-Pack Pro C18 reverse-phase column (250 mm × 4.6 mm l.D., S–5 μm, 12 nm) (YMC Co., Ltd., Japan). The isocratic mobile phase of acetonitrile-methanol (9:1) was pumped at a flow rate of 1 ml min-1, and the eluent was detected at 254 nm.
Screening of a cosmid library of S. griseus genomic DNA
As screening probes, the DNA fragments of KS, ALS and FkbH-like protein were firstly amplified from S. griseus DSM 2608 chromosomal DNA. The gene amplification yielded DNA fragments having about 590 bp for KS gene, 520 bp for ALS gene and 600 bp for FkbH-like protein gene, respectively (Additional file 1: Figure S1). The amplified KS probe had a highly similar nucleotide sequence over 95% with TrdAIII gene of Streptomyces sp. SCSIO1666 (GenBank No. HQ852227.1) and TamAIII gene of Streptomyces sp. 307–9 (GenBank No. GU385216.1). The amplified ALS probe also showed the high homology around 92% in nucleotide sequences with bfmK gene of Kitasatospora setae KM-6054 (GenBank No. NC_016109.1) and bafZ gene of S. lohii (GenBank No. GU390405.1). The amplified probe for FkbH-like protein fragment also exhibited the high homology over 90% in nucleotide sequences with bfmE gene of K. setae KM-6054 (GenBank No. NC_016109.1) and bafE gene of S. lohii (GenBank No. GU390405.1).
The cosmid library was made in SuperCos1 vector at Bam HI site by ligating the large fragments of chromosomal DNA partially digested with Mbo I. The recombinant cosmid were in vitro packaged and transfected into E. coli XL1-blue MRF' strain. Around 5×104 to 5×105 transfected bacterial colonies per μg DNA were counted on LB plate containing ampicillin. The obtained cosmid clones were diluted 104-106 fold to give around 5×103 colonies per LB plate, and screened the bafilomycin biosynthetic gene cluster using the amplified probes labeled with α-[32P]- dCTP.
One positive clone, pSGB1 was firstly screened based on the multiple strong signals with KS probes, which indicates the presence of type I multi-modular PKS responsible for the biosynthesis of type I polyketide molecule (Additional file 1: Figure S2). To extend the biosynthetic gene cluster in pSGB1 cosmid by chromosome walking, the amplified DNA fragments of ALS gene and FkbH-like protein gene were employed as the second probes for colony hybridization. Among 63 positive cosmid clones screened using KS probes, only 2 cosmid clones were hybridized with ALS probe and only 3 clones with FkbH probe during the second screening. As shown in Additional file 1: Figure S2, the chosen cosmid clones, pSGB23 and pSGB20, gave a strong signal with ALS probe or FkbH probe in addition to KS probe.
Gene organization of bafilomycin biosynthetic gene cluster
Gene organization of bafilomycin biosynthetic gene cluster of Streptomyces griseus DSM 2608
Number of amino acid
The closest gene
acyl-CoA ligase (partial)
modular polyketide synthase I
modular polyketide synthase II
modular polyketide synthase III
modular polyketide synthase IV
modular polyketide synthase V
3-hydroxyacyl-CoA dehydrogenase (NAD-dependent)
acyl carrier protein
acyl-CoA dehydrogenases (FAD-dependent)
AfsR family transcriptional regulator
Putative CoA ligase
XRE family transcriptional regulator
GntR family transcriptional regulator
putative transcriptional regulator
Osmosensitive K+ channel histidine kinase
Streptomyces sp. Mg1
K+-transporting ATPase subunit C
K+-transporting ATPase subunit B (partial)
Streptomyces griseus subsp. griseus
Five genes for BafSI to BafSV were deduced to be the type Ι PKS genes responsible for the biosynthesis of main macrolactone backbone of bafilomycin. At the upstream of gene cluster, three genes for BafBI to BafBIII were presumed to be engaged in the biosynthesis of flavensomycinyl moiety of bafilomycin B1. At the downstream of PKS genes, the genes involved in the biosynthesis of methoxymalonyl-CoA from glycerol as a polyketide precursor (Chan and Thomas 2010) were also found from BafAI to BafAV. Two genes for transcription regulators in the families of SARP and LuxR were also found at the downstream of gene cluster. However, it is uncertain whether ten gene products located at downstream of gene cluster are related to bafilomycin biosynthesis or not.
Functional characterization of bafilomycin biosynthetic gene cluster
In order to confirm whether the cloned gene cluster is really involved in the biosynthesis of bafilomycin, the gene for a dehydratase domain of module 12 (DH12) of PKS and an FkbH-like gene in S. griseus chromosome was disrupted by PCR-targeted gene disruption method (Gust et al. 2003). Firstly the disruption cassettes containing 5′-flanking upstream region and 3′-flanking downstream region for gene disruption, two FRT sites, apramycin resistance gene for selection, and ori T for conjugation in the size of 1.4 kb were amplified using pIJ773 plasmid as a template (Additional file 1: Figure S3). Those amplified disruption cassettes were used for disruption of each gene in pSGB20 cosmid by homologous recombination in E. coli BW25113/pIJ790. The disrupted cosmid, pSGB20-DH12-apr or pSGB20-FkbH-apr, was transformed again into E. coli ET12567 containing conjugal plasmid pUZ 8002. This E. coli strain was conjugated in the presence of MgCl2 with wild-type S. griseus spores. After 5 day-cultivation, the positive conjugants, S. griseus DH12-apr or S. griseus FkbH-apr, which was resistant to apramycin but sensitive to kanamycin were selected. The chromosomal DNAs of disrupted strains were confirmed by PCR analysis (Additional file 1: Figure S4).
Plecomacrolide antibiotic is an unusual macrolide antibiotic which has a structural element of 6-membered hemiacetal ring connected to the macrolactone ring. The unusual structure drew the scientist’s interests about their biosynthetic pathway. Among plecomacrolide antibiotics, the concanamycin biosynthetic gene cluster was firstly reported from S. neyagawaensis (Haydock et al. 2005), and the biosynthetic pathway of plecomacrolide backbone was partly deduced.
We cloned an 87.4 kb chromosomal region of S. griseus DSM 2608, including presumable biosynthetic gene cluster of bafilomycin. This gene cluster was confirmed by metabolite analysis after gene disruption.
Thus the first PKS having 4 modules encoded from bafSI starts the polyketide synthesis from isobutyl group, and extend its length by incorporating 1 acetyl group and 2 propionyl groups, making 9 carbon backbone. Considering the chemical structure of bafilomycin, the hemiacetal ring can be formed at this step before further polyketide extension.
The polyketide biosynthesis is continuously mediated by following PKS proteins directed by BafSII, BafSIII, BafSIV, and the final BafSV. Those PKSs are comprised of 8 modules which can incorporate 1 acetyl group, 2-methoxyacetyl groups and 5 propionyl groups during polyketide extension. Since the incorporation of the methoxy groups at C-2 and C-14 position of bafilomycin macrolactone is originated from glycerol by feeding experiments of radiolabeled precursors (Schuhmann and Grond 2004;Schuhmann et al. 2007), it is imagined that module 6 and module 12 might transfer 2-methoxyacetyl group by methoxymalonyl-CoA originated from glycerol.
The compound made after macrolactone formation is bafilomycin A1, which can be modified to bafilomycin C1 by esterification with fumaryl group at hydroxyl group in hemiacetal ring, and further to bafilomycin B1 by linking 2-amino-3-hydroxy-cyclopenta-2-enone, finally building-up flavensomycinyl moiety (Figure 5B). In the bafilomycin biosynthetic gene cluster cloned here, the genes responsible for the biosynthesis of 2-amino-3-hydroxy-cyclopenta-2-enone were also found. The 2-amino-3-hydroxy-cyclopenta-2-enone production through 2 steps of enzyme reaction was reported previously (Zhang et al. 2010). Firstly, 5-aminolevulinate synthase can catalyze the formation of 5-aminolevulinic acid from glycine and succinyl-CoA, which is then converted to 5-aminolevulinyl-CoA by acyl-CoA ligase. Even though 5-aminolevulinyl-CoA is spontaneous converted to 2,5-piperidinedione due to its instability, it is more easily cyclized to 2-amino-3-hydroxy-cyclopenta-2-enone in the presence of 5-aminolevulinate synthase. Finally this compound can be connected with fumaryl group by amide synthetase.
For the incorporation of fumaryl group into flavensomycinyl moiety, it was assumed that fumaric acid is firstly converted to fumaryl-CoA by BafCI (acyl CoA ligase), and then connected to bafilomycin polyketde backbone by BafCII (malonyl transferase). However, the catalytic properties of those enzymes should be further characterized.
This work was supported by Korea Research Fund (grant number NRF-2011-0006078).
- Bierman M, Logan R, O’Brien K, Seno ET, Rao RN, Schoner BE: Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene 1992, 116: 43–49. 10.1016/0378-1119(92)90627-2PubMedView Article
- Bowman EJ, Sibers A, Aldendorf K: Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells. Proc Natl Acad Sci USA 1988, 85: 7972–7976. 10.1073/pnas.85.21.7972PubMed CentralPubMedView Article
- Chan YA, Thomas MG: Recognition of (2S)-aminomalonyl-acyl carrier protein (ACP) and (2R)-hydroxymalonyl-ACP by acyltransferases in zwittermicin A biosynthesis. Biochemistry 2010, 49: 3667–3677. 10.1021/bi100141nPubMed CentralPubMedView Article
- Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000, 97: 6640–6645. 10.1073/pnas.120163297PubMed CentralPubMedView Article
- Dröse S, Altendorf K: Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J Exp Biol 1997, 200: 1–8. 1997PubMed
- Farina C, Gagliardi S: Selective inhibition of osteoclast vacuolar H(+)-ATPase. Curr Pharm Design 2002, 8: 2033–2048. 10.2174/1381612023393369View Article
- Gust B, Challis GL, Fowler K, Kieser T, Chater KF: PCR-targeted streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. PNAS 2003, 100: 1541–1546. 10.1073/pnas.0337542100PubMed CentralPubMedView Article
- Hagenmaier H-P, Werner G, Drautz H, Holst H, Zähner H, Brandes W, Reinecke P, Zoebelein G, Stendel W, Andrews P, Schaller K: Bafilomycin pesticide. US Patent 1985. 4,558,139
- Haydock SF, Appleyard AN, Mironenko T, Lester J, Scott N, Leadlay PF: Organization of the biosynthetic gene cluster for the macrolide concanamycin A in Streptomyces neyagawaensis ATCC 27449. Microbiology 2005, 151: 3161–3169. 10.1099/mic.0.28194-0PubMedView Article
- Ichikawa N, Oguchi A, Ikeda H, Ishikawa J, Kitani S, Watanabe Y, Nakamura S, Katano Y, Kishi E, Sasagawa M, Ankai A, Fukui S, Hashimoto Y, Kamata S, Otoguro M, Tanikawa S, Nihira T, Horinouchi S, Ohnishi Y, Hayakawa M, Kuzuyama T, Arisawa A, Nomoto F, Miura H, Takahashi Y, Fujita N: Genome sequence of Kitasatospora setae NBRC 14216: An evolutionary snapshot of the family Streptomycetaceae. DNA Res 2010, 17: 393–406. 10.1093/dnares/dsq026PubMed CentralPubMedView Article
- Ishikawa J, Hotta K: Frame plot: a new implementation of the frame analysis for predicting protein-coding regions in bacterial DNA with high G+C content. FEMS Microbiol Lett 1999, 174: 251–253. 10.1111/j.1574-6968.1999.tb13576.xPubMedView Article
- Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA: Practical Streptomyces Genetics. The John Innes Foundation, Norwich, UK; 2000.
- Kinashi H, Someno K, Sakaguchi K: Isolation and characterization of concanamycin A, B and C. J Antibiot 1984, 37: 2509–2511.View Article
- Moon S-S, Hwang W-H, Chung YR: New cytotoxic bafilomycin C 1 -amide produced by Kitasatospora cheerisanensis . J Antibiot 2003, 56: 856–861. 10.7164/antibiotics.56.856PubMedView Article
- Ohta E, Kubota NK, Ohta S, Suzuki M, Ogawa T, Yamasaki A, Ikegami S: Micromonospolides A-C, new macrolides from Micromonospora sp. Tetrahedron 2001, 57: 8463–8467. 10.1016/S0040-4020(01)00843-2View Article
- O'Shea MG, Rickards RW, Rothschild JM, Lacey E: Absolute configurations of macrolide antibiotics of the bafilomycin and leucanicidin groups. J Antibiot 1997, 50: 1073–1077. 10.7164/antibiotics.50.1073PubMedView Article
- Otoguro K, Nakagawa A, Omura S: Setamycin, a 16-membered macrolide antibiotic. Identification and nematocidal activity. J Antibiot 1988, 41: 250–252. 10.7164/antibiotics.41.250PubMedView Article
- Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. CSH Press, NY, USA; 1989.
- Seto H, Tajima I, Akao H, Furihata K, Otake N: The isolation and structures of hygrolidin amide and defumarylhygrolidin. J Antibiot 1984, 37: 610–613. 10.7164/antibiotics.37.610PubMedView Article
- Shacka JJ, Klocke BJ, Roth KA: Autophagy, bafilomycin and cell death. The “A-B-Cs” of plecomacrolide-induced neuroprotection. Autophagy 2006, 2: 228–230.PubMedView Article
- Schuhmann T, Grond S: Biosynthetic investigation of the V-type ATPase inhibitors bafilomycin A 1 , B 1 and concanamycin A. J Antibiot 2004, 57: 655–661. 10.7164/antibiotics.57.655PubMedView Article
- Schuhmann T, Vollmar D, Grond S: Biosynthetic origin of the methoxy extender unit in bafilomycin and concanamycin using stereospecifically labeled precursors. J Antibiot 2007, 60: 53–60.View Article
- Sun Y, Hong H, Gillies F, Spencer JB, Leadlay PF: Glyceryl-S-acyl carrier protein as an intermediate in the biosynthesis of tetronate antibiotics. ChemBioChem 2008, 9: 150–156. 10.1002/cbic.200700492PubMedView Article
- Wenzel SC, Williamson RM, Grünanger C, Xu J, Gerth K, Martinez RA, Moss SJ, Carroll BJ, Grond S, Unkefer CJ, Müller R, Floss HG: On the biosynthetic origin of methoxymalonyl-acyl carrier protein, the substrate for incorporation of "glycolate" units into ansamitocin and soraphen A. J Am Chem Soc 2006, 128: 14325–14336. 10.1021/ja064408tPubMedView Article
- Werner G, Hagenmaier H, Drautz H, Baumgartner A, Zähner H: Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot 1984, 37: 110–117. 10.7164/antibiotics.37.110PubMedView Article
- Xu J, Cheng T, Feng HT, Pavlos NJ, Zheng MH: Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis. Histol Histopathol 2007, 22: 443–454.PubMed
- Zhang W, Bolla ML, Kahne D, Walsh CT: A three enzyme pathway for 2-amino-3-hydroxycyclopent-2-enone formation and incorporation in natural product biosynthesis. J Am Chem Soc 2010, 132: 6402–6411. 10.1021/ja1002845PubMed CentralPubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.